Horizon Therapeutics Financial Health

How is Horizon Therapeutics's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: HZNP's short term assets ($3.2B) exceed its short term liabilities ($791.1M).

Long Term Liabilities: HZNP's short term assets ($3.2B) exceed its long term liabilities ($3.1B).


Debt to Equity History and Analysis

Debt Level: HZNP's net debt to equity ratio (13.6%) is considered satisfactory.

Reducing Debt: HZNP's debt to equity ratio has reduced from 184% to 51.9% over the past 5 years.

Debt Coverage: HZNP's debt is well covered by operating cash flow (55.1%).

Interest Coverage: HZNP's interest payments on its debt are well covered by EBIT (11x coverage).


Balance Sheet


Discover healthy companies